Medical News

RSS

Only one-third of young women complete HPV regimen

Despite strong evidence of its effectiveness, few of the young women who are eligible for the human papillomavirus (HPV) vaccine take it, according to research presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10.

10 Nov 2010

New York Times examines HIV prevention products undergoing clinical trials

The New York Times examines several products being studied in clinical trials that researchers hope will one day prevent sexual transmission of HIV. The newspaper describes the ongoing trials of a vaginal microbicide gel containing the antiretroviral tenofovir which was found to reduce the risk of HIV infection in women by 39 percent, writing, "[o]ther clinical trials will report their results in 2011 and 2012 and, if all goes well, researchers hope to have a product or two ready to enter the market by 2013."

10 Nov 2010

Albert Einstein researcher receives Medal of Honor from American Cancer Society

Albert Einstein College of Medicine of Yeshiva University researcher Jeffrey Pollard, Ph.D., has received the prestigious Medal of Honor in Basic Science from the American Cancer Society (ACS) in recognition of his research into the critical role the tumor microenvironment plays in modulating cancer behavior, specifically the role that members of the innate immune cells called macrophages play both in normal development and in promoting tumor progression. These macrophages could hold the key to more targeted cancer treatments.

10 Nov 2010

Enrollment complete in Nabi's second NicVAX Phase III clinical trial for nicotine addiction

Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.

10 Nov 2010

Patient satisfaction vital to establish an accountable care organization

According to a recent survey from HealthLeaders Media, 80% of healthcare executives believe the patient experience will be a business imperative that drives referrals, volume and revenue as much as clinical quality.

10 Nov 2010

Insurance premiums rise, high-deductible plans increase, health costs can lead to elder bankruptcy

The Washington Post: "According to experts and industry insiders, recent trends suggest [health insurance] rates will continue to rise and employers will continue to shift more of the cost of health insurance onto workers - asking them to shoulder a larger share of premiums, for instance, or increasing out-of-pocket costs such as deductibles and co-pays."

10 Nov 2010

Senior Scientific receives QTDP grants for cancer detection and treatment

Manhattan Scientifics, Inc. (OTCBB: MHTX) announced that Senior Scientific LLC is the recipient of four grants totaling $702,899 awarded by the Qualifying Therapeutic Discovery Grant Program.

10 Nov 2010

FlexStent Femoropopliteal SE Stent System FIM study results presented at VIVA conference

Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.

10 Nov 2010

Affluent people face higher risk of melanoma

According to scientists at the Cancer Prevention Institute of California (CPIC), affluent people are at a much higher risk of melanoma than the rest of the population of whites in California.

10 Nov 2010

Common foot disorders more prevalent among African Americans

Common foot disorders such as flat feet, corns and bunions are more prevalent among African Americans than in whites, a new study by University of North Carolina at Chapel Hill researchers has found.

10 Nov 2010

Home smoking restrictions needed to reduce tobacco-related carcinogens in children's urine

Ninety percent of children who lived in a house where an adult smoked had evidence of tobacco-related carcinogens in their urine, according to research presented at the Ninth AACR Frontiers in Cancer Prevention Research Conference, held here from Nov 7-10, 2010.

10 Nov 2010

Health reform policy: Flexible spending, device taxes and waivers

One health law provision will be a bummer for people who use the tax-free dollars stored in flexible spending accounts, Kaiser Health News reports. "Starting in January, you'll no longer be able to use your FSA for over-the-counter drugs and medicines unless you have a doctor's prescription. Experts agree that the new rules will likely discourage people from tapping their FSAs for routine purchases of aspirin, vitamins, cough medicine and other drugstore essentials" (Andrews, 11/8).

10 Nov 2010

Iris BioTechnologies awarded $245,000 grant under QTDP Program

Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, is pleased to announce that the company has been awarded $245,000, the maximum amount given for a grant under the US Qualifying Therapeutic Discovery Project (QTDP) Program.

10 Nov 2010

New study reveals finger length can indicate high testosterone levels

Potential investors might wish to examine the fingers of their financial advisor prior to signing over any savings. A new study from Concordia University has found the length between the second and fourth finger is an indicator of high levels of prenatal testosterone, risk-taking and potential financial success in men.

10 Nov 2010

Investigations examine Medicare’s dialysis system, CT scanners and drugs

ProPublica reports on the costs and risks associated with dialysis: "In 1972, after a month of deliberation, Congress launched the nation's most ambitious experiment in universal health care: a change to the Social Security Act that granted comprehensive coverage under Medicare to virtually anyone diagnosed with kidney failure, regardless of age or income.

10 Nov 2010

Younger patients unable to cope with pain and emotional issues of cancer

Younger adult cancer patients have the most difficulty coping with the pain and emotional issues of cancer, in spite of their potentially better survival odds, according to a University of Michigan Health System study.

10 Nov 2010

Physical activity lowers risk of endometrial cancer

Women who exercise for 150 minutes a week or more may see a reduced risk of endometrial cancer, despite whether or not they are overweight, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.

10 Nov 2010

Republicans' committee plans take shape amid health reform questions

The Hill: "House Ways and Means Chairman-to-be Dave Camp (R-Mich.) is making his case for repealing and replacing the healthcare overhaul, touting his own version of a bill that he says would reduce premiums." Camp made his case in a USA Today editorial and says the GOP plan would reduce premiums by up to 10 percent. Camp says his plan would reform medical malpractice lawsuits, allow Americans to buy health insurance across state lines, and gives "states the flexibility to make changes that best meet the needs of their residents."

10 Nov 2010

Undergraduate students win Gates Foundation grant for low-cost ultrasound system

A team of University of Washington undergraduate students was among 65 research groups that today learned they had won one of the Bill & Melinda Gates Foundation's $100,000 Grand Challenges Explorations grants.

10 Nov 2010

Federal appellate court rules in favor of Merck in TEMODAR patent infringement suit

Merck & Co., Inc. said today that a federal appellate court ruled in its favor in a TEMODAR patent infringement suit against Barr Laboratories, an affiliate of Teva Pharmaceuticals.

10 Nov 2010